Teijin Limited

TSE:3401 株式レポート

時価総額:JP¥301.5b

Teijin 過去の業績

過去 基準チェック /06

Teijinの収益は年間平均-61.5%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間5.4% 3.1%割合で 増加しています。

主要情報

-61.53%

収益成長率

-61.49%

EPS成長率

Chemicals 業界の成長6.58%
収益成長率3.08%
株主資本利益率-20.76%
ネット・マージン-8.97%
次回の業績アップデート11 May 2026

最近の業績更新

Recent updates

3401: Deepening Loss Outlook Will Still Signal Weak Earnings And Overvaluation

Analysts have revised their price target on Teijin to ¥1,368 from ¥1,328. The new target reflects updated assumptions for revenue growth, profit margins, the discount rate and future P/E multiples.

3401: Stable Assumptions Will Still Signal Weak Earnings And Overvaluation

Analysts have kept their ¥1,328 price target for Teijin unchanged, citing only minor model adjustments to discount rate, revenue growth, profit margin and future P/E assumptions that do not materially alter their view on the shares. Valuation Changes Fair Value: Modelled fair value remains unchanged at ¥1,328.

3401: Higher P/E Assumptions Will Still Signal Weak Earnings Outlook

Narrative Update on Teijin The analyst fair value estimate for Teijin has been revised from ¥1,298 to ¥1,328, with analysts linking this change to updated assumptions for revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value: Revised slightly higher from ¥1,298 to ¥1,328.

3401: Higher P/E Assumptions Will Still Signal Weak Earnings Outlook

Analysts have raised their price target for Teijin from ¥1,256 to ¥1,298, reflecting slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E. Valuation Changes Fair Value: revised from ¥1,256 to ¥1,298, a modest uplift in the model output.

3401: Modest Margin Gains And Merger Plans Will Still Signal Weak Outlook

Analysts have kept their ¥1,256 price target for Teijin unchanged, citing a slightly lower discount rate, an expected shift from a 1.66% revenue decline to a 0.21% revenue increase, a modest uptick in profit margin, and a reduced assumed future P/E as key factors supporting their maintained view. What's in the News A board meeting is scheduled for December 1, 2025, to consider a basic agreement for an absorption-type merger between Teijin Frontier Co., Ltd., a wholly owned Teijin subsidiary, and Asahi Kasei Advance Corporation, a wholly owned Asahi Kasei subsidiary, with Teijin Frontier as the surviving company (Key Developments).

3401: Aramid Impairment Will Drive Weaker Outlook Despite Merger Plans

Analysts have maintained their fair value estimate for Teijin at ¥1,256. A slightly lower discount rate and a marginally reduced future P/E assumption support a modestly refined price target narrative.

3401: Aramid Impairment Will Drive Cautious Outlook Despite Merger Plans

Analysts have nudged their fair value estimate for Teijin up from ¥1,246 to ¥1,256, citing slightly softer assumed revenue declines, a modestly lower discount rate, and a small adjustment to future P/E expectations as the key drivers of the change. What's in the News Teijin plans a board meeting on December 1, 2025 to consider a basic agreement for an absorption type merger between Teijin Frontier Co., Ltd.

3401: Aramid Impairment And Joint Venture Integration Will Shape Balanced Outlook

Analysts kept their fair value estimate for Teijin steady at ¥1,246, with only small tweaks to the discount rate, long term revenue and margin assumptions, and the future P/E used in their models. This reflects fine tuning rather than a change in their overall view.

3401: Aramid Impairment And Joint Venture Integration Will Define Balanced Outlook

Analysts have nudged their price target on Teijin modestly higher to ¥1,246. This reflects slightly lower perceived risk and a marginally cheaper forward earnings multiple, even as growth and margin assumptions remain essentially unchanged.

Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00

Dec 19
Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00

3401: Aramid Impairment And Earnings Resilience Will Shape Balanced Forward Prospects

Analysts have nudged their price target on Teijin slightly higher to JPY 1,246, citing a modestly lower perceived risk profile and stable long term earnings assumptions, despite limited changes to underlying growth and margin forecasts. What's in the News Board meeting scheduled for December 1, 2025, to approve a basic agreement for an absorption type merger between Teijin Frontier and Asahi Kasei Advance, with Teijin Frontier as the surviving company and later becoming a joint venture of Teijin and Asahi Kasei (company disclosure) Resin and plastic processing business briefing session held for analysts and investors, focusing on the outlook and strategy for this segment (company event) Impairment loss of JPY 48.4 billion recorded on fixed assets in the aramid business for the six months ended September 30, 2025, driven by intensifying competition and adverse exchange rate movements, with charges booked in cost of sales and SG&A (company results) Full-year 2025 to 2026 earnings guidance revised downward, with operating income forecast cut from JPY 20 billion to JPY 5 billion and profit attributable to owners of parent now expected to be a loss of JPY 10 billion, mainly due to the aramid impairment and weaker materials and equity method contributions (guidance update) Valuation Changes Fair Value: unchanged at approximately ¥1,246 per share, implying no revision to the analyst central valuation.

Teijin's (TSE:3401) Dividend Will Be ¥25.00

Dec 05
Teijin's (TSE:3401) Dividend Will Be ¥25.00

3401: Impairment Loss And Margin Stability Will Define Balanced Investment Prospects

The analyst price target for Teijin has been reaffirmed at ¥1,246 as analysts cite stable forecasts and no material changes in forecasts for discount rate, revenue growth, profit margin, or projected valuation multiples. What's in the News Teijin held a Resin & Plastic Processing Business Briefing Session as part of their Analyst/Investor Day.

3401: Revenue Outlook Will Moderate Risks While Supporting Balanced Opportunity

Analysts have raised their price target for Teijin from ¥1,180 to ¥1,246. This reflects an improved revenue growth outlook and a lower discount rate in updated forecasts.

Global Demand For Advanced Composites Will Expand Opportunities

Key Takeaways Refocus on high-margin specialty materials and healthcare segments, combined with operational reforms, is expected to drive margin expansion and more stable earnings. Innovation in sustainable materials and divestment of low-yield businesses position the company for new growth opportunities and improved earnings quality.

Teijin (TSE:3401) Has Debt But No Earnings; Should You Worry?

Jul 24
Teijin (TSE:3401) Has Debt But No Earnings; Should You Worry?

Are Investors Undervaluing Teijin Limited (TSE:3401) By 45%?

Apr 14
Are Investors Undervaluing Teijin Limited (TSE:3401) By 45%?

Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00

Mar 22
Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00

Is Teijin (TSE:3401) A Risky Investment?

Feb 03
Is Teijin (TSE:3401) A Risky Investment?

Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00

Dec 31
Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00

Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00

Dec 17
Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00

Teijin (TSE:3401) Has Announced A Dividend Of ¥25.00

Dec 03
Teijin (TSE:3401) Has Announced A Dividend Of ¥25.00

Is There An Opportunity With Teijin Limited's (TSE:3401) 46% Undervaluation?

Dec 01
Is There An Opportunity With Teijin Limited's (TSE:3401) 46% Undervaluation?

Some Confidence Is Lacking In Teijin Limited's (TSE:3401) P/S

Nov 07
Some Confidence Is Lacking In Teijin Limited's (TSE:3401) P/S

Be Wary Of Teijin (TSE:3401) And Its Returns On Capital

Oct 17
Be Wary Of Teijin (TSE:3401) And Its Returns On Capital

Teijin (TSE:3401) Has A Somewhat Strained Balance Sheet

Sep 18
Teijin (TSE:3401) Has A Somewhat Strained Balance Sheet

Investor Optimism Abounds Teijin Limited (TSE:3401) But Growth Is Lacking

Aug 04
Investor Optimism Abounds Teijin Limited (TSE:3401) But Growth Is Lacking

A Look At The Fair Value Of Teijin Limited (TSE:3401)

Jun 10
A Look At The Fair Value Of Teijin Limited (TSE:3401)

There May Be Underlying Issues With The Quality Of Teijin's (TSE:3401) Earnings

May 21
There May Be Underlying Issues With The Quality Of Teijin's (TSE:3401) Earnings

Teijin (TSE:3401) Will Be Looking To Turn Around Its Returns

Apr 09
Teijin (TSE:3401) Will Be Looking To Turn Around Its Returns

Teijin (TSE:3401) Will Pay A Dividend Of ¥15.00

Mar 21
Teijin (TSE:3401) Will Pay A Dividend Of ¥15.00

Teijin Limited's (TSE:3401) Share Price Matching Investor Opinion

Mar 16
Teijin Limited's (TSE:3401) Share Price Matching Investor Opinion

Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥15.00

Feb 28
Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥15.00

収支内訳

Teijin の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

TSE:3401 収益、費用、利益 ( )JPY Millions
日付収益収益G+A経費研究開発費
31 Dec 25909,237-81,603197,4370
30 Sep 25949,011-76,620250,4830
30 Jun 25993,247-82,148226,0650
31 Mar 251,005,471-77,711270,3300
31 Dec 241,080,075-50,562281,4530
30 Sep 241,033,772-44,786195,80142,560
30 Jun 241,059,05113,490264,3290
31 Mar 241,032,77310,599190,83042,560
31 Dec 231,013,251-7,190194,34131,935
30 Sep 231,014,802-25,811178,44531,935
30 Jun 231,019,758-23,108176,69031,935
31 Mar 231,018,751-17,695173,96631,935
31 Dec 221,004,148-9,733173,05233,341
30 Sep 22983,1229,163172,87833,341
30 Jun 22943,99920,628168,25833,341
31 Mar 22926,05423,158163,72133,341
31 Dec 21913,776-7,646174,47032,719
30 Sep 21895,756-1,088166,66232,719
30 Jun 21883,288-2,558160,19932,719
31 Mar 21836,512-6,662153,68332,719
31 Dec 20816,02721,908150,15934,482
30 Sep 20811,84720,804151,76034,482
30 Jun 20818,23820,171154,88634,482
31 Mar 20853,74625,252158,50534,482
31 Dec 19876,39934,470159,94736,422
30 Sep 19885,21131,593161,04136,422
30 Jun 19886,83636,353159,27536,422
31 Mar 19888,58945,057159,03636,422
31 Dec 18879,95846,582159,98935,926
30 Sep 18869,74950,281156,51435,926
30 Jun 18853,12051,641155,32635,926
31 Mar 18834,98545,556152,65535,926
31 Dec 17820,78855,795152,99735,416
30 Sep 17792,89657,946150,45235,416
30 Jun 17765,30452,093151,51235,416
31 Mar 17741,29150,133149,17735,416
31 Dec 16734,63530,233158,22033,285
30 Sep 16751,74027,996157,42133,285
30 Jun 16772,40931,336187,4560
31 Mar 16790,74831,090154,02433,285
31 Dec 15799,01441,260145,43732,366
30 Sep 15800,82938,724159,27216,950
30 Jun 15796,8781,456140,81132,366

質の高い収益: 3401は現在利益が出ていません。

利益率の向上: 3401は現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 3401は利益が出ておらず、過去 5 年間で損失は年間61.5%の割合で増加しています。

成長の加速: 3401の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: 3401は利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -0.4% ) と比較することは困難です。


株主資本利益率

高いROE: 3401は現在利益が出ていないため、自己資本利益率 ( -20.76% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/05/01 20:48
終値2026/05/01 00:00
収益2025/12/31
年間収益2025/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Teijin Limited 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。17

アナリスト機関
Mikiya YamadaBarclays
Akiko KuwaharaBofA Global Research
Atsushi IkedaCitigroup Inc